Sign in

CIK 0001347178 · Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
030491827
Phone
202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
  1. DEFA14A Proxy Proxy Materials
  2. S-8 Other Securities Offered to Employees in Benefit Plans
  3. DEFA14A Proxy Proxy Materials
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. DEFA14A Proxy Proxy Materials
  6. CT ORDER Other Confidential Order
  7. DEFA14A Proxy Proxy Materials
  8. DEFA14A Proxy Proxy Materials
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. DEFA14A Proxy Proxy Materials
  11. DEFA14A Proxy Proxy Materials
  12. CT ORDER Other Confidential Order
  13. S-8 Other Securities Offered to Employees in Benefit Plans
  14. CT ORDER Other Confidential Order
  15. DEFA14A Proxy Proxy Materials
  16. CT ORDER Other Confidential Order
  17. S-8 Other Securities Offered to Employees in Benefit Plans
  18. DEFA14A Proxy Proxy Materials
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. EFFECT Other Notice of Effectiveness

Page 3 of 5 · 93 filings